BridgeBio Pharma (BBIO) Other financing activities (2018 - 2026)
BridgeBio Pharma (BBIO) reported Other financing activities of $5.5 million for Q1 2026, up 583.25% on a YoY basis from $800000.0 in Q1 2025, and up 144.18% sequentially from -$12.4 million in Q4 2025.
BridgeBio Pharma (BBIO) Other financing activities (2018 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 9 years of Other financing activities data on file, last reported at $5.5 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 583.25% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (up 2491.63% YoY), and the FY2025 full-year result was $2.2 million, changed N/A from the prior year.
- Other financing activities climbed to $5.5 million in Q1 2026, from -$12.4 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $11.3 million in Q3 2025 to a low of -$12.4 million in Q4 2025.
- A 5-year average of $585812.5 and a median of $668500.0 in 2024 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 37520.0% in 2025, while the deepest fall reached 1431.31% in 2025.
- Tracing BBIO's Other financing activities over 5 years: stood at $2.6 million in 2022, then tumbled by 264.11% to -$4.2 million in 2023, then soared by 80.75% to -$808000.0 in 2024, then sank by 1431.31% to -$12.4 million in 2025, then soared by 144.18% to $5.5 million in 2026.
- Business Quant data shows BBIO's Other financing activities at $5.5 million in Q1 2026, -$12.4 million in Q4 2025, and $11.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.47 Mn |
| Mar 31, 2026 | 5.47 Mn |
| Dec 31, 2025 | -12.37 Mn |
| Dec 31, 2025 | -12.37 Mn |
| Sep 30, 2025 | 11.29 Mn |
| Sep 30, 2025 | 11.29 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Mar 31, 2025 | 800,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | -808,000.00 |
| Dec 31, 2024 | -808,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 537,000.00 |
| Mar 31, 2024 | 537,000.00 |
| Dec 31, 2023 | -4.20 Mn |
| Dec 31, 2023 | -4.20 Mn |